Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma
"Improving access to GLP-1 treatments in the coming years will be a key driver for the Indian pharmaceutical industry, helping address the growing burden of lifestyle diseases such as obesity and diabetes," said Ganorkar